Employees
~4,316
About Daiichi Sankyo US
Key Facts
Approximately 4,316 employees globally
Headquartered in Basking Ridge, New Jersey, United States
Operates in Pharmaceutical Manufacturing
Executive Leadership Team
Caitlin Barnabo
Executive Director, Global Oncology Medical Affairs Strategy and Operational Excellence
Since 2026
Carol (Rehkopf) Cirigliano, MS, Reg. Sci., MBA
Executive Director, Quality Assurance Compliance
Since 2023
Chirag Desai
Executive Director, Companion Diagnostics Commercialization and Biomarker Strategy
Since 2026
James F.
Chief Digital Transformation Officer, Global Head of Digital Transformation, Daiichi Sankyo
Since 2024
Organizational Chart — Preview
See the Full Org Chart with Contact Details
Unlock reporting lines, direct contacts, connection paths, and business insights for all Daiichi Sankyo US's employees
Daiichi Sankyo US Executive Leadership Team
Caitlin Barnabo
Executive Director, Global Oncology Medical Affairs Strategy and Operational Excellence
Since 2026
Carol (Rehkopf) Cirigliano, MS, Reg. Sci., MBA
Executive Director, Quality Assurance Compliance
Since 2023
Chirag Desai
Executive Director, Companion Diagnostics Commercialization and Biomarker Strategy
Since 2026
Christian Blin
President
The objective of that role is to support the further build up of Global R&D capacity and capabilities, concurrently to being Head of Global R&D Finance & Procurement.
Since 2024
James F.
Chief Digital Transformation Officer, Global Head of Digital Transformation, Daiichi Sankyo
Global CDXO
Since 2024
Business Focus Areas
Business Focus Areas
Daiichi Sankyo, Inc. is a member of the Daiichi Sankyo group of companies and is focused on the development of oncology therapies and specialty medicines.OncologySpecialty Medicine
🔓 Unlock Full Org Chart to see the full technographic profile including all applications, infrastructure details, vendor contracts, and technology evaluation signals.